Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
+533,500
New +$14M 0.03% 476
2026
Q1
– Sell
-43,600
Closed -$1.09M – 3165
2025
Q4
$1.09M Buy
43,600
+3,900
+10% +$98.3K ﹤0.01% 1731
2025
Q3
$1.01M Buy
39,700
+4,700
+13% +$116K ﹤0.01% 1838
2025
Q2
$848K Sell
35,000
-50,000
-59% -$1.17M ﹤0.01% 1892
2025
Q1
$2.15M Buy
85,000
+41,900
+97% +$1.1M ﹤0.01% 1378
2024
Q4
$1.14M Buy
+43,100
New +$1.17M ﹤0.01% 1746

Other funds holding PFE

PEAK6's PFE Position: Q2 2026 in Review

PEAK6 opened a new position in Pfizer (PFE) in Q2 2026: 75,818 shares worth $1.83M. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: PEAK6 previously reported a position in PFE as recently as Q4 2025.

PEAK6 first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PEAK6 held 75,818 shares of Pfizer worth $1.83M as of Q2 2026.
  • Pfizer was a new PEAK6 position in Q2 2026.
  • Pfizer made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1375 holding.
  • PEAK6 first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.